The Leadership Team at Cingulate Therapeutics drives the strategic direction of the company, focusing on the development and commercialization of innovative pharmaceutical products through the Precision Timed Release™ (PTR) drug delivery platform. Comprising key executives such as the Chief Medical Officer, Chief Science Officer, and Chairman & CEO, the team collaborates to ensure that scientific innovation aligns with business goals, regulatory compliance, and patient needs.
View all